These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36280000)

  • 1. Acute graft-versus-host disease presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective cohort study.
    Hung YT; Chen YW; Huang Y; Lin YJ; Chen CB; Chung WH
    J Am Acad Dermatol; 2023 Apr; 88(4):792-801. PubMed ID: 36280000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and therapeutic dilemma in Stevens-Johnson syndrome-like acute graft-versus-host disease after liver transplantation: A case report.
    Hung YT; Chang YR; Wang HN; Lee WC; Lee CF; Chen CB
    Front Immunol; 2022; 13():917782. PubMed ID: 36059444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated intravascular coagulation in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chen CB; Hsu TH; Chung-Yee Hui R; Lu CW; Chen WT; Chiang PH; Wang CW; Chuang SS; Yang JY; Yang SY; Chang SY; Hsiao YC; Kao KC; Hu HC; Wu TS; Hsu CW; Hui-Kang Ma D; Chen SY; Tian YC; Cheng CY; Chen CH; Chi MH; Wu MY; Liu RF; Wang CH; Chang YC; Lin JY; Ho HC; Yu-Wei Lin Y; Chang CJ; Lin YJ; Ku CL; Hung SI; Chung WH;
    J Am Acad Dermatol; 2021 Jun; 84(6):1782-1791. PubMed ID: 32828861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
    Gleghorn KL; Voigt C; Kelly B
    Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of the prognostic nutritional index and red blood cell distribution width-to-albumin ratio for the prediction of severity of and mortality associated with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Zhang Z; Yu K; Jiang Z; Liu O; Wan C; Wu H; Cao X
    J Dermatol; 2023 Apr; 50(4):518-524. PubMed ID: 36478458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical markers for histopathological diagnosis and differentiation of acute cutaneous graft-versus-host disease.
    Wegner J; Weidenthaler-Barth B; Engelbert J; Knothe M; Braun C; Helbig D; Sacher C; Kreft A; Wagner EM; Ziemer M; Meyer RG; von Stebut E
    Exp Dermatol; 2021 Dec; 30(12):1814-1819. PubMed ID: 34223669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
    Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
    World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmoplakin I/II immunohistochemical staining may be a helpful tool in differentiating cutaneous graft versus host disease from the erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis spectrum disorders.
    Irwin T; Yeung CCS; Shinohara MM
    J Cutan Pathol; 2024 Jan; 51(1):76-82. PubMed ID: 37691139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis in Hong Kong.
    Cheung CMT; Chang MM; Li JJX; Chan AWS
    Hong Kong Med J; 2024 Apr; 30(2):102-109. PubMed ID: 38531617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Harr T; French LE
    Orphanet J Rare Dis; 2010 Dec; 5():39. PubMed ID: 21162721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stevens-Johnson syndrome and toxic epidermal necrolysis: a 10-year experience in a burns unit.
    Houschyar KS; Tapking C; Borrelli MR; Nietzschmann I; Puladi B; Ooms M; Rein S; Houschyar M; Duscher D; Maan ZN; Reumuth G; Branski LK; Modabber A; Kluwig D; Schmitt L; Philipp-Dormston WG; Yazdi AS; Siemers F
    J Wound Care; 2021 Jun; 30(6):492-496. PubMed ID: 34121430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: frozen-section diagnosis.
    Hosaka H; Ohtoshi S; Nakada T; Iijima M
    J Dermatol; 2010 May; 37(5):407-12. PubMed ID: 20536645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018.
    Sunaga Y; Kurosawa M; Ochiai H; Watanabe H; Sueki H; Azukizawa H; Asada H; Watanabe Y; Yamaguchi Y; Aihara M; Mizukawa Y; Ohyama M; Hama N; Abe R; Hashizume H; Nakajima S; Nomura T; Kabashima K; Tohyama M; Takahashi H; Mieno H; Ueta M; Sotozono C; Niihara H; Morita E; Kokaze A
    J Dermatol Sci; 2020 Dec; 100(3):175-182. PubMed ID: 33046331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycoplasma-induced Stevens-Johnson syndrome/toxic epidermal necrolysis: Case-control analysis of a cohort managed in a specialized center.
    Liew YCC; Choo KJL; Oh CC; Pang SM; Yeo YW; Lee HY
    J Am Acad Dermatol; 2022 Apr; 86(4):811-817. PubMed ID: 33915240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.
    Zhang J; Lu CW; Chen CB; Wang CW; Chen WT; Cheng B; Ji C; Chung WH
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1295-1304.e6. PubMed ID: 35131514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature.
    Ziemer M; Kardaun SH; Liss Y; Mockenhaupt M
    Br J Dermatol; 2012 Mar; 166(3):575-600. PubMed ID: 22014091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.